Cardiovascular Devices Market Size

  • Report ID: 3272
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Cardiovascular Devices Market Outlook:

Cardiovascular Devices Market size was over USD 69.06 billion in 2025 and is poised to exceed USD 146.36 billion by 2035, growing at over 7.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cardiovascular devices is evaluated at USD 73.91 billion.

The rising of cardiovascular disease risk across followed by an increasing old age population will propel the market growth. As per the World Health Organization, the number of old people aged 60 and above in the U.S. is greater than the number of children less than 5 years of age as of 2020. Also, the number of old people aged 60 and over will double by 2050 to reach 2.1 billion, and the number of old people aged 80 years and above is estimated to grow thrice from 2020 to 2050 and reach 426 million.

In addition, factors such as increase in over-the-counter medicine availability, rising investments, and the expanding number of awareness campaigns on the administration of cardiovascular devices are thought to be driving the global cardiovascular devices market growth. Moreover, an increase in incidences of cardiac diseases such as heart attacks, coronary heart disease, and cardiac arrhythmia will boost the market revenue. According to the Centers for Disease Control and Prevention, heart disease claimed the lives of almost 697,000 Americans in 2020.


Cardiovascular Devices Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cardiovascular devices is evaluated at USD 73.91 billion.

The global cardiovascular devices market size was worth over USD 69.06 billion in 2025 and is poised to grow at a CAGR of around 7.8%, reaching USD 146.36 billion revenue by 2035.

North America cardiovascular devices market will dominate over 40.8% share by 2035, driven by the rising prevalence of cardiovascular diseases and increasing healthcare expenditure.

Key players in the market include B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Terumo Corporation, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, GE Group, Siemens Healthcare GmbH.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos